You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) on Thursday announced positive topline results from the Phase 3 TALAPRO-3 study evaluating TALZENNA (talazoparib) in combination with XTANDI (enzalutamide) in patients with homologous...
19 March 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) said on Thursday that it has obtained IVDR CE marking for its BIOFIRE SPOTFIRE Respiratory/Sore Throat plus (R/STplus) Panel and Panel Mini, enabling near-patient diagn...
19 March 2026 - Swedish life science tools company Mabtech announced on Wednesday a strategic collaboration with Sai Life Sciences, a global Contract Research Organisation (CRO).Under the agreement, Sai's Boston discovery laboratory will serve a...
19 March 2026 - UK biotechnology company IsomAb Ltd announced on Wednesday the appointment of Dr Philip Brainin as chief executive officer and member of the board of directors.IsomAb is developing isoform-specific antibody therapeutics for atheroscle...
19 March 2026 - Elaris FlexCo, an Austrian biotechnology company developing vaccines against serious bacterial infections, announced on Wednesday that it has signed a licensing agreement with French vaccine company Valneva SE (Nasdaq:VALN) (Euronext ...
18 March 2026 - South Korean biopharmaceutical company Samsung Bioepis Co Ltd on Wednesday announced a global development and commercialisation agreement with Sandoz Group AG (SIX:SDZ), a generics and biosimilars company based in Switzerland.The agre...
18 March 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, an investigational oral glucosyl...